Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHELLING JL")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

UN ASPECT PARTICULIER DE LA PHARMACOTHERAPIE: LA COMPLIANCENEMITZ I; SCHELLING JL.1979; REV. MED. SUISSE ROMANDE; CHE; DA. 1979; VOL. 99; NO 7; PP. 451-460; BIBL. 118 REF.Article

LES CONSEQUENCES DE L'ELIMINATION D'UN MEDICAMENT COMBINE. PASSAGE DE L'ANTISACER COMPOSE A L'ANTISACER: ATTENTION.DE CROUSAZ G; SCHELLING JL.1977; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1977; VOL. 107; NO 51; PP. 1932-1936; ABS. ANGL.; BIBL. 12 REF.Article

EFFECT OF PINDOLOL, A BETA RECEPTOR ANTAGONIST, IN HYPERTHYROIDISMSCHELLING JL; SCAZZIGA B; DUFOUR RJ et al.1973; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1973; VOL. 14; NO 2; PP. 158-164; BIBL. 22 REF.Serial Issue

EFFECT OF THE MENSTRUAL CYCLE, ORAL CONTRACEPTION AND PREGNANCY ON FOREARM BLOOD FLOW, VENOUS DISTENSIBILITY AND CLOTTING FACTORS.FAWER R; DETTLING A; WEIHS D et al.1978; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1978; VOL. 13; NO 4; PP. 251-257; BIBL. 34 REF.Article

CONCENTRATION URINAIRE ET EFFET ANTIBACTERIEN DE TETRACYCLINES A COURTE ET LONGUE DUREE D'ACTIONVILLANI F; BOHNET A; SAKELLARIDES E et al.1975; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1975; VOL. 105; NO 11; PP. 341-344; ABS. ANGL.; BIBL. 7REF.Article

CONCENTRATION PLASMATIQUE DE PHENYTOINE CHEZ LES EPILEPTIQUES - INTERET POUR LE CLINICIENDEONNA T; DE CROUSAZ G; MAGRINI G et al.1975; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1975; VOL. 105; NO 30; PP. 936-941; ABS. ANGL.; BIBL. 17 REF.Article

JUDGMENTS OF TRAINED OBSERVERS ON ADVERSE DRUG REACTIONSBLANG S; LEUENBERGER P; BERGER JP et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 5 PART. 1; PP. 493-498; BIBL. 9 REF.Article

FREQUENCE DES PRESCRIPTIONS DE MEDICAMENTS ET DE LEURS EFFETS INDESIRABLES DANS UN DEPARTEMENT DE MEDECINE.JAMES D; HALLER E; ROSSELET G et al.1978; SCHWEIZ. MED. WSCHR.; CHE; DA. 1978; VOL. 108; NO 33; PP. 1270-1277; ABS. ENG; BIBL. 10 REF.Article

QUELQUES FACTEURS INTERVENANT DANS LES REACTIONS ADVERSES MEDICAMENTEUSES.BERGER JP; HALLER E; BLANC S et al.1975; SCHWEIZ. MED. WSCHR.; SCHWEIZ.; DA. 1975; VOL. 105; NO 50; PP. 1706-1708; ABS. ANGL.; BIBL. 5 REF.Article

IMMERSION AND VENOUS OCCLUSION PLETHYSMOGRAPHY IN PATIENTS WITH IDIOPATHIC ORTHOSTATIC HYPOTENSIONJAEGER P; FAWER R; BRUNNER HR et al.1981; CLIN. EXP. HYPERTENS.; ISSN 0148-3927; USA; DA. 1981; VOL. 3; NO 5; PP. 919-927; BIBL. 24 REF.Article

ENALAPRL MALEATE AND A LYSINE ANALOGUE (MK-521): DISPOSITION IN MANULM EH; HICHENS M; GOMEZ HJ et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 3; PP. 357-362; BIBL. 15 REF.Article

ENALAPRIL MALEATE AND A LYSINE ANALOGUE (MK-521) IN NORMAL VOLUNTEERS; RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN ANGIOTENSIN SYSTEMBIOLLAZ J; SCHELLING JL; DES COMBES BJ et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 3; PP. 363-368; BIBL. 11 REF.Article

  • Page / 1